A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
By Sam A. Rushing – Advanced Cryogenics, Ltd. Special to The Digest This article on CO2 usage in the food industry is one in a series for the applications which are predominant and important in the carbon dioxide industry. This subject is […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
First things first, this is a story of syngas fermentation, not the definitive story, though it’s pretty definitive on the Jupeng Bio story. For the definitive story of the entire landscape of syngas fermentation, it would have been required to bring back the late Richard Forster of LanzaTech, the late Jim Gaddy of BRI, into […]
By Cynthia Thyfault, CEO, QuantaVision Special to The Digest Many promising ventures face a daunting challenge: translating groundbreaking technology into market success. This challenge isn’t merely a matter of technical prowess but often a strategic one. Much like the generals of today who mastered the art of warfare, tech entrepreneurs must navigate the treacherous terrain […]
